Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum
In these situations, a health care provider may decide its best to stop treatment altogether
Thus, a systematic review of the efficacy of GLP-1RAs in terms of their effect on the underlying pathology of AD and improvement of cognitive functions, which included 6 articles that met the criteria (4 randomized control studies and 2 protocol studies) [53], indicates that GLP-1RA therapy in AD did not alter -amyloid and tau protein biomarkers and did not improve cognitive abilities, but demonstrated potential metabolic and neuroprotective benefits
Participants taking Wegovy more frequently reported: nausea diarrhea constipation vomiting The trial also revealed compelling secondary benefits, with improvements in key comorbidities, including: type 2 diabetes obesity cardiovascular risk markers Most notably, people taking Wegovy lost significantly more weight than those receiving a placebo an average of 10% of body weight compared to just 2%
Women with conditions like polycystic ovary syndrome (PCOS) often experience irregular periods and reduced fertility due to hormonal imbalances
